Application of real options analysis for pharmaceutical R&D project valuation—Empirical results from a survey
- 28 February 2006
- journal article
- Published by Elsevier in Research Policy
- Vol. 35 (3) , 343-354
- https://doi.org/10.1016/j.respol.2005.12.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Prospects for productivityNature Reviews Drug Discovery, 2004
- The valuation of a NDA using a 6-fold compound optionResearch Policy, 2004
- Trends in development cyclesNature Reviews Drug Discovery, 2002
- The valuation of compound optionsPublished by Elsevier ,2002
- Laboratory Evidence on How Managers Intuitively Value Real Growth OptionsJournal of Business Finance & Accounting, 1997
- Real options in practice: an exploratory survey of how finance officers deal with flexibility in capital appraisalManagement Accounting Research, 1997
- Longer Patents for Increased Generic Competition in the USPharmacoEconomics, 1996
- Option pricing: A simplified approachJournal of Financial Economics, 1979
- The Pricing of Options and Corporate LiabilitiesJournal of Political Economy, 1973